All Raw materials and supply chain (bioprocess) articles
-
ArticleStaying competitive within the evolving CDMO model
Dr Abdelaziz Toumi, CEO of Lupin Manufacturing Solutions, shares his perspective on what differentiates credible CDMO entrants as pharmaceutical pipelines shift towards structurally complex molecules, the scientific imperatives shaping oncology and peptide manufacturing and the talent challenge that he believes will define competitive positioning in the decade ahead.
-
ArticleThermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility
Real-time monitoring has become standard practice in temperature-controlled distribution. The differentiator now is whether organisations can convert signals into decisions early enough to prevent excursions, reduce waste and strengthen resilience. As Vijay Paliwal, Vice President, Global Advanced Solutions & Customer Experience at Cold Chain Technologies explains, that shift is driving a new operating model for cold chain management: thermal assurance.
-
ArticleMedicines as strategic assets: the new politics of pharma supply
Ahead of CPHI Americas in June, Sherma Ellis Daal explores how informed, cross-sector dialogue in the pharmaceutical supply chain can help navigate an increasingly complex global system.
-
ArticleBreaking the biomanufacturing mould: a patient-centric CDMO approach
Helen Bickley, Chief Quality Officer, FUJIFILM Biotechnologies reveals a new agile approach to biologics production that adopts a modular strategy for greater flexibility and ease.
-
NewsEU Commission agree to move Critical Medicines Act towards approval
Milestone agreement furthers proposals that help prevent drug shortages in Europe.
-
NewsCPHI Americas 2026 returns to Philadelphia with AI, regulatory focus
The annual conference for contract pharmaceutical manufacturing partners returns to Pennsylvania, centering on regulatory shifts, AI and biotech innovation.
-
NewsNovel NMR-based method could facilitate safer API manufacturing
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
-
NewsTrump imposes 100 percent tariff on imported pharmaceuticals
US administration proffers leeway on tariffs for some drugs, with UK exports benefitting from exemption under the recent UK-US partnership.
-
ReportPharma Horizons: Trends in Pharmaceutical Manufacturing
EPR’s 2026 pharma manufacturing trends report covers the key developments in supply chain, quality, drug development, new modalities and beyond.
-
NewsFDA launches PreCheck pilot programme for US pharma manufacturers
The regulator’s new programme aims to create more efficient regulatory review processes for new pharmaceutical manufacturing facilities.
-
NewsLilly chooses Pennsylvania for $3.5bn injectables manufacturing facility
Investment in the Lehigh Valley site finalises the last of the pharma company’s four new US manufacturing plants, supporting its onshoring of domestic medicine production.
-
NewsAstraZeneca makes $15bn manufacturing investment in China
Landmark, decade-long investment plan aims to support the pharma company’s 2030 revenue objective of $80 billion.
-
NewsEurope marks key milestone in adopting Critical Medicines Act
EU Parliament agrees clear priorities for future negotiations on the act, including investing in pharma manufacturing capacity.
-
NewsEU concludes major free trade agreement with Mercosur countries
European pharma industry acknowledges the progress made, particularly with partial tariff reductions, but said further provisions could have been achieved.
-
NewsEurope makes progress in its bid to tackle medicine shortages
And as the Critical Medicines Act advances, so too does the Biotech Act, with the moves attracting mixed support from the region’s pharma industry.
-
NewsBicycle Therapeutics strikes uranium deal for sustainable radiopharmaceuticals
UK biotech commits to scale up of 228Th extraction and a long-term supply agreement to facilitate production of thousands of doses of 212Pb for cancer therapies annually.
-
NewsLilly to establish third new US manufacturing facility in Alabama
Announcement of Eli Lilly and Company's fourth new US manufacturing plant is expected within the next few weeks.
-
WebinarRealising autonomous pharmaceutical operations
Is operational complexity limiting your performance? Discover how autonomous technologies are reducing risk and improving quality in pharma organisations.
-
News
European Commission calls for bio-based innovation in new EU Bioeconomy Strategy
Changes proposed in the EU body’s regulatory framework aim to create a competitive and sustainable European bioeconomy.
-
News
AstraZeneca furthers US manufacturing commitment with $2bn Maryland investment
The move is part of biopharma's $50 billion pledge to US medicines manufacturing and R&D.